Cargando…

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients

BACKGROUND: Despite years of experience with vancomycin (VAN), the optimal method to monitor VAN therapy in pediatric patients is still unknown. Recent pediatric data indicate serum trough concentrations lower than 10–20 mg/L or 15–20 mg/L based on indication may achieve an AUC(24)> 400 mg hours/...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Krista, Kumar, Madan, Nelson, Allison, Bhagat, Palak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810141/
http://dx.doi.org/10.1093/ofid/ofz360.1416
_version_ 1783462175580356608
author Weaver, Krista
Kumar, Madan
Nelson, Allison
Bhagat, Palak
author_facet Weaver, Krista
Kumar, Madan
Nelson, Allison
Bhagat, Palak
author_sort Weaver, Krista
collection PubMed
description BACKGROUND: Despite years of experience with vancomycin (VAN), the optimal method to monitor VAN therapy in pediatric patients is still unknown. Recent pediatric data indicate serum trough concentrations lower than 10–20 mg/L or 15–20 mg/L based on indication may achieve an AUC(24)> 400 mg hours/L. The primary study objective was to compare AUC(24) to goal VAN serum trough concentrations (STC). METHODS: A retrospective chart review of pediatric patients who received intravenous VAN June 1, 2018 to December 31, 2018 was completed. AUC(24) was calculated using a trapezoidal method with 2 steady-state serum concentrations. A serum peak concentration was drawn 1 hour and 15 minutes following the end of infusion and an STC was drawn 30 minutes prior to infusion. RESULTS: During 25 admissions, 12 patients had a first AUC(24) at goal and 13 patients had a first AUC(24) below goal. Of 41 AUC(24) calculations, 27 AUC(24)s were ≥400 mg hours/L (group 1), and 14 AUC(24)s were <400 mg hours/L (group 2). Median AUC(24) was 561 mg hours/L for group 1 vs. 344.5 mg hours/L for group 2 (P < 0.001). Correlating Cmin and Ctrough (Ctr) for group 1 and group 2 were 12 mg/L and 13.5 mg/L vs. 6.4 mg/L and 7.3 mg/L, respectively (P < 0.001). Figure 1 shows the pharmacokinetic parameters for each group. Spearman correlation between AUC(24) and Cmin was 0.87. Of the 35 subtherapeutic VAN STCs, 20 (57.1%) achieved an AUC(24) ≥400 mg hours/L (P = 0.08). Subgroup analysis of AUC(24) 400–600 mg hours/L showed a median AUC(24) of 519 mg hours/L with correlating Cmin and Ctr of 10.6 mg/L and 11.9 mg/L, respectively. The MIC was <1 in 90.9% of cases (Figure 2). The mean VAN dose required to achieve an AUC(24) ≥400 mg hours/L was 77.7 mg/kg/day; dosing frequency did not appear to affect AUC(24) outcome. Time to culture clearance was 2 days in group 1 and 6.5 days in group 2 (P = 0.24). No cases of nephrotoxicity were identified despite AUC(24) values ranging from 265–1294 mg hours/L. CONCLUSION: AUC(24) monitoring using a 2-sample trapezoidal method was successfully implemented at this institution. The results of this study align with previous pediatric studies, supporting the use of lower serum trough concentration goals of 10–15 mg/L. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810141
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68101412019-10-28 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients Weaver, Krista Kumar, Madan Nelson, Allison Bhagat, Palak Open Forum Infect Dis Abstracts BACKGROUND: Despite years of experience with vancomycin (VAN), the optimal method to monitor VAN therapy in pediatric patients is still unknown. Recent pediatric data indicate serum trough concentrations lower than 10–20 mg/L or 15–20 mg/L based on indication may achieve an AUC(24)> 400 mg hours/L. The primary study objective was to compare AUC(24) to goal VAN serum trough concentrations (STC). METHODS: A retrospective chart review of pediatric patients who received intravenous VAN June 1, 2018 to December 31, 2018 was completed. AUC(24) was calculated using a trapezoidal method with 2 steady-state serum concentrations. A serum peak concentration was drawn 1 hour and 15 minutes following the end of infusion and an STC was drawn 30 minutes prior to infusion. RESULTS: During 25 admissions, 12 patients had a first AUC(24) at goal and 13 patients had a first AUC(24) below goal. Of 41 AUC(24) calculations, 27 AUC(24)s were ≥400 mg hours/L (group 1), and 14 AUC(24)s were <400 mg hours/L (group 2). Median AUC(24) was 561 mg hours/L for group 1 vs. 344.5 mg hours/L for group 2 (P < 0.001). Correlating Cmin and Ctrough (Ctr) for group 1 and group 2 were 12 mg/L and 13.5 mg/L vs. 6.4 mg/L and 7.3 mg/L, respectively (P < 0.001). Figure 1 shows the pharmacokinetic parameters for each group. Spearman correlation between AUC(24) and Cmin was 0.87. Of the 35 subtherapeutic VAN STCs, 20 (57.1%) achieved an AUC(24) ≥400 mg hours/L (P = 0.08). Subgroup analysis of AUC(24) 400–600 mg hours/L showed a median AUC(24) of 519 mg hours/L with correlating Cmin and Ctr of 10.6 mg/L and 11.9 mg/L, respectively. The MIC was <1 in 90.9% of cases (Figure 2). The mean VAN dose required to achieve an AUC(24) ≥400 mg hours/L was 77.7 mg/kg/day; dosing frequency did not appear to affect AUC(24) outcome. Time to culture clearance was 2 days in group 1 and 6.5 days in group 2 (P = 0.24). No cases of nephrotoxicity were identified despite AUC(24) values ranging from 265–1294 mg hours/L. CONCLUSION: AUC(24) monitoring using a 2-sample trapezoidal method was successfully implemented at this institution. The results of this study align with previous pediatric studies, supporting the use of lower serum trough concentration goals of 10–15 mg/L. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810141/ http://dx.doi.org/10.1093/ofid/ofz360.1416 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Weaver, Krista
Kumar, Madan
Nelson, Allison
Bhagat, Palak
1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title_full 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title_fullStr 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title_full_unstemmed 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title_short 1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
title_sort 1552. correlation between vancomycin serum trough concentrations and area under the curve in pediatric patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810141/
http://dx.doi.org/10.1093/ofid/ofz360.1416
work_keys_str_mv AT weaverkrista 1552correlationbetweenvancomycinserumtroughconcentrationsandareaunderthecurveinpediatricpatients
AT kumarmadan 1552correlationbetweenvancomycinserumtroughconcentrationsandareaunderthecurveinpediatricpatients
AT nelsonallison 1552correlationbetweenvancomycinserumtroughconcentrationsandareaunderthecurveinpediatricpatients
AT bhagatpalak 1552correlationbetweenvancomycinserumtroughconcentrationsandareaunderthecurveinpediatricpatients